Article
hURAT1 Transgenic Mouse Model for Evaluating Targeted Urate-Lowering Agents.
International journal of rheumatic diseases - 1 Jan 2025
Cai Weiyan, Yang Miyi, Zhao Qinghe, Yi Guohua, Lin Peihui, Chen Apeng, De Gejing
Abstract excerpt
BACKGROUND: Urate transporter 1 (URAT1) is a well-known therapeutic target for reducing urate levels in the treatment of hyperuricemia and gout. However, current pharmacological studies have failed to evaluate the efficacy of URAT1 inhibitors in non-primate animal models. We established a human URAT1 (hURAT1) transgenic knock-in (KI) mouse model to assess uricosuric agents' effectiveness and characterize...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
